ArticleTrials2023

Evaluating newly approved drugs in combination regimens for multidrug-resistant tuberculosis with fluoroquinolone resistance (endTB-Q): study protocol for a multi-country randomized controlled trial.

S B Patil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.